EPISODE · May 9, 2023 · 24 MIN
Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD
from Rx for Biotech · host Podcast Host Chris Leidli
In this podcast episode, Dr. Philip Kantoff, the CEO, CMO, and Co-Founder of Convergent Therapeutics reviews the company's efforts to develop next-generation radiopharmaceuticals for the treatment of cancer.
What this episode covers
In this podcast episode, Dr. Philip Kantoff, the CEO, CMO, and Co-Founder of Convergent Therapeutics reviews the company's efforts to develop next-generation radiopharmaceuticals for the treatment of cancer.
NOW PLAYING
Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m